Siren LLC’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-16,515
Closed -$147K – 110
2025
Q4
$147K Sell
16,515
-79
-0.5% -$987 ﹤0.01% 113
2025
Q3
$267K Hold
16,594
– – 0.01% 113
2025
Q2
$338K Hold
16,594
– – 0.02% 105
2025
Q1
$290K Hold
16,594
– – 0.02% 114
2024
Q4
$374K Hold
16,594
– – 0.02% 115
2024
Q3
$301K Buy
+16,594
New +$342K 0.02% 109

Other funds holding KRSA

Siren LLC's KRSA Position: Q1 2026 in Review

Siren LLC sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2026, closing a stake of 16,515 shares — an estimated $147K sold.

Siren LLC first reported a position in KRSA in Q3 2024 and held it in 6 quarters. The position peaked at $374K in Q4 2024. 16 funds tracked by Wall St. Rank hold KRSA as of Q1 2026.

  • Siren LLC reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Siren LLC sold 16,515 Korsana Biosciences, Inc. Common Stock shares in Q1 2026, an estimated $147K.
  • Siren LLC first reported a position in Korsana Biosciences, Inc. Common Stock in Q3 2024 and held it in 6 quarters.
  • Siren LLC's Korsana Biosciences, Inc. Common Stock position peaked at $374K in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2026.

Based on Siren LLC's 13F filing for Q1 2026, filed 14 May 2026.